Invention Grant
US07176022B2 Directly injectable formulations which provide enhanced cryoprotection of cell products
有权
直接注射制剂，其提供增强的细胞产物的低温保护
- Patent Title: Directly injectable formulations which provide enhanced cryoprotection of cell products
- Patent Title (中): 直接注射制剂，其提供增强的细胞产物的低温保护
-
Application No.: US10323664Application Date: 2002-12-20
-
Publication No.: US07176022B2Publication Date: 2007-02-13
- Inventor: David Frey , Andy Lin , Gautam Banik
- Applicant: David Frey , Andy Lin , Gautam Banik
- Applicant Address: US CA South San Francisco
- Assignee: Cell Genesys, Inc.
- Current Assignee: Cell Genesys, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: DLA Piper Rudnick Gray Cary
- Main IPC: C12N5/00
- IPC: C12N5/00
Abstract:
This invention provides compositions and methods for cryoprotection of recombinant live cancer cells. Specifically, an improved cryoprotective medium is provided which includes a hydroxyethyl starch and/or derivative thereof alone or in combination with either DMSO or glycerol.
Public/Granted literature
- US20040121300A1 Directly injectable formulations which provide enhanced cryoprotection of cell products Public/Granted day:2004-06-24
Information query
